Stabilized CD16a Expression on Pluripotent Stem Cell-Derived Natural Killer Cells
2015-12
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Stabilized CD16a Expression on Pluripotent Stem Cell-Derived Natural Killer Cells
Authors
Published Date
2015-12
Publisher
Type
Thesis or Dissertation
Abstract
Human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) have been shown to successfully generate functional hematopoietic cells of multiple lineages. One of the cells that these studies have shown is possible to generate are cytotoxic natural killer (NK) cells. These pluripotent stem cell-derived NK cells could potentially be used as a cell-based therapy to treat a wide range of cancers. A potent method through which NK cells kill their targets is antibody-dependent cell-mediated cytotoxicity (ADCC). During this process an Fc gamma receptor, CD16a, recognizes antibody coated target cells and leads to the stimulation of the NK cell’s cytotoxic pathways. However, upon CD16a activation, a metalloprotease known as ADAM17 has been shown to cleave CD16a leading to a decrease in NK cell ADCC. This project seeks to generate genetically modified NK cells that have CD16a expression stabilized to maximize ADCC. One method to accomplish this is the generation of a non-cleavable version of CD16a. This cDNA construct has been transfected into iPSCs using Sleeping Beauty transposase to stably express CD16a. These cell’s CD16a molecules are resistant to cleavage upon cell activation and are also highly expressed on the surface of the NK cells. Preliminary testing has shown that when combined with antibodies specific to their cognate target ligand, these cells have a greater cytolytic response than untransfected peripheral blood NK cells (PBNK). Also, CRISPR-Cas9 has been employed to knock-out ADAM17. Going forward, comparing the cytotoxicity of these two NK cells will show which is best to employ in the treatment of cancers that express ligands for therapeutic antibodies that have proven refractory to other therapies and adjuvants.
Keywords
Description
University of Minnesota M.S. thesis. December 2015. Major: Stem Cell Biology. Advisor: Dan Kaufman. 1 computer file (PDF); iv, 48 pages.
Related to
Replaces
License
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Blum, Robert. (2015). Stabilized CD16a Expression on Pluripotent Stem Cell-Derived Natural Killer Cells. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/191195.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.